These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 12823844)

  • 1. SLE - Rituximab in lupus.
    Eisenberg R
    Arthritis Res Ther; 2003; 5(4):157-9. PubMed ID: 12823844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does B cell depletion have a role to play in the treatment of systemic lupus erythematosus?
    Gorman C; Leandro M; Isenberg D
    Lupus; 2004; 13(5):312-6. PubMed ID: 15230284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B cell depletion therapy in systemic lupus erythematosus.
    Anolik J; Sanz I; Looney RJ
    Curr Rheumatol Rep; 2003 Oct; 5(5):350-6. PubMed ID: 12967516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-cell-targeted therapy for systemic lupus erythematosus.
    Sabahi R; Anolik JH
    Drugs; 2006; 66(15):1933-48. PubMed ID: 17100405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting B cells in SLE: the experience with rituximab treatment (anti-CD20).
    Eisenberg R
    Endocr Metab Immune Disord Drug Targets; 2006 Dec; 6(4):345-50. PubMed ID: 17214580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B lymphocytes in systemic lupus erythematosus: lessons from therapy targeting B cells.
    Looney RJ; Anolik J; Sanz I
    Lupus; 2004; 13(5):381-90. PubMed ID: 15230297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of inflammatory immunologic disease 4. B cell targeting therapy using the anti-CD20 antibody rituximab in inflammatory autoimmune diseases.
    Tanaka Y
    Intern Med; 2007; 46(16):1313-5. PubMed ID: 17704614
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of SLE with anti-CD20 monoclonal antibody.
    Looney RJ; Anolik J; Sanz I
    Curr Dir Autoimmun; 2005; 8():193-205. PubMed ID: 15564722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-cell targeted therapies in systemic lupus erythematosus: successes and challenges.
    Harvey PR; Gordon C
    BioDrugs; 2013 Apr; 27(2):85-95. PubMed ID: 23456653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-B cell therapy (rituximab) in the treatment of autoimmune diseases.
    Chambers SA; Isenberg D
    Lupus; 2005; 14(3):210-4. PubMed ID: 15807198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Connective tissue diseases: The conundrum of B cell depletion in SLE.
    Sanz I
    Nat Rev Rheumatol; 2009 Jun; 5(6):304-5. PubMed ID: 19491910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-cell-targeted therapy for systemic lupus erythematosus: an update.
    Ding C; Foote S; Jones G
    BioDrugs; 2008; 22(4):239-49. PubMed ID: 18611066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [B cell targeting therapy using the anti-CD20 antibody in autoimmune diseases].
    Tanaka Y
    Yakugaku Zasshi; 2009 Jun; 129(6):675-9. PubMed ID: 19483410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted B-cell depletion therapy in childhood-onset systemic lupus erythematosus: progress to date.
    Marks SD; Tullus K
    Paediatr Drugs; 2007; 9(6):371-8. PubMed ID: 18052407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rituximab - shadow, illusion or light?
    van Vollenhoven RF
    Autoimmun Rev; 2012 Jun; 11(8):563-7. PubMed ID: 22036829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus.
    Eisenberg R; Albert D
    Nat Clin Pract Rheumatol; 2006 Jan; 2(1):20-7. PubMed ID: 16932648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Progress in B-cell targeting therapy for the treatment of systemic lupus erythematosus].
    Tanaka Y
    J UOEH; 2011 Jun; 33(2):173-81. PubMed ID: 21702122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relevance of lymphocyte subsets to B cell-targeted therapy in systemic lupus erythematosus.
    Nakayamada S; Iwata S; Tanaka Y
    Int J Rheum Dis; 2015 Feb; 18(2):208-18. PubMed ID: 25557245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective B cell depletion with rituximab in the treatment of autoimmune diseases.
    Kneitz C; Wilhelm M; Tony HP
    Immunobiology; 2002 Dec; 206(5):519-27. PubMed ID: 12607727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of CD40 and CD80 on B cells in patients with life-threatening systemic lupus erythematosus after successful treatment with rituximab.
    Tokunaga M; Fujii K; Saito K; Nakayamada S; Tsujimura S; Nawata M; Tanaka Y
    Rheumatology (Oxford); 2005 Feb; 44(2):176-82. PubMed ID: 15494350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.